A molecular assay to predict survival in resected non-squamous non-small-cell lung cancer
- Correspondence to Dr Jeng-Shing Wang, Antai Medical Care Cooperation Antai Tian-Sheng Memorial Hospital, Department of Thoracic Medicine, Pingtung, & Department of Senior Citizen Service Management, Yuh-Ing Junior College, Kaohsiung, Pingtung 928, Taiwan; wangjs6{at}hotmail.com
This 14-gene expression assay that uses quantitative PCR on formalin-fixed paraffin-embedded tissue samples was developed and validated and compared with conventional staging. This assay was developed in patients with resected non-squamous non-small-cell lung cancer (NSCLC) at one centre, and then validated in patients with resected stage I non-squamous NSCLC …
